Bill

Bill > H3796


MA H3796

MA H3796
Relative to patient assessment and notification prior to prescribing certain medications


summary

Introduced
05/20/2021
In Committee
05/20/2021
Crossed Over
Passed
Dead
12/31/2022

Introduced Session

192nd General Court

Bill Summary

Relative to patient assessment and notification prior to prescribing certain medications. Public Health.

AI Summary

This bill amends Massachusetts law to require healthcare providers to conduct additional assessments and obtain written informed consent from patients, and their parents or legal guardians if the patient is a minor, prior to prescribing certain medications. The key provisions include: 1. Defining "benzodiazepines" and "non-benzodiazepine hypnotics" as specific types of medications primarily used to treat conditions like insomnia, anxiety, and muscle relaxation. 2. Requiring providers to review the patient's medical history, assess alternative treatments, and discuss the risks of addiction, overdose, and long-term use before prescribing benzodiazepines, non-benzodiazepine hypnotics, or extended-release long-acting opioids for the first time. 3. Mandating providers to obtain the patient's (and their parent/guardian's, if a minor) written informed consent before issuing these prescriptions for the first time. 4. Requiring an additional review and consent process before issuing a third prescription for opioid medications. The goal of this bill is to improve patient awareness and safety when being prescribed potentially addictive or high-risk medications.

Committee Categories

Health and Social Services

Sponsors (10)

Last Action

Accompanied a new draft, see H4814 (on 05/26/2022)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...